Design and baseline characteristics of the Xarelto Post-Authorization Safety & Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS).

Satoshi OgawaKazuo MinematsuTakanori IkedaTakanari KitazonoJyoji NakagawaraSusumu MiyamotoYuji MurakawaYohei OhashiMakiko TakeichiYutaka OkayamaSatoshi YamanakaLyo Inuyama

Published in: Journal of arrhythmia (2018)

Data from this study will supplement those from the J-ROCKET AF and provide practical information for the optimal use of rivaroxaban for stroke prevention in Japanese patients with AF (Clinicaltrials.gov: NCT01582737).

Keyphrases

atrial fibrillation
randomized controlled trial
systematic review
venous thromboembolism
machine learning
healthcare
brain injury
electronic health record